Replies to post #2801 on Genprex Inc (GNPX)

[breezy1]

Wonder who’s shopping this for buyout?

[BusterDave]

Ph.2 or Ph-6 doesn't matter except in the sense that it determines the amount of time until this treatment is publicly available.

Assuming positive data the only question that matters is, "How long until the FDA approves this for use?"

What do you think?

[Chasing]

Geeeez. You are talking about two entirely different drug combo therapies; one was with Tarceva and the other is with Tagrisso. We "pivoted" from combo with Tarceva to a combo with Tagrisso.
Nothing has been leaked. There's no technical or non technical phase 3. Learn something about Fast Track and accelerate Review.


https://www.precisiononcologynews.com/cancer/genprex-focus-developing-immunogene-therapy-start-lung-cancer-trials-year#.Xk7w2Ep7nIU

Phase 1 and 2 have been completed late 2019. Further clinical studies are underway (as of January, 2020). These studies may not be technically designated Phase 3. But, "further clinical studies are underway" (January, 2020). I believe that the results of these "further clinical studies" have been leaked to large investors resulting in 84 million share sales on the open market on Feb. 14.